Shenzhen Chipscreen Biosciences Co., Ltd

Short Term Long Term Short Term Comparison Long Term Comparison
  • 688321
  • 1d-4.62%
  • 1w-5.39%
  • 1m12.93%
  • 1y-36.56%
ATH
  • ATH Price$102.00
  • ATH Date2019-08-15
  • % since ATH-80.56%
  • % to ATH414.37%
ATL
  • ATL Price$13.01
  • ATL Date2024-02-05
  • % from ATL52.42%
  • Last Low Price$13.01
  • Last Low Date2024-02-05
  • % From Last Low52.42%
IPO
  • IPO Price$125.00
  • % Current ROI USD-84.14%
  • ATH Price$102.00
  • % ROI ATH 78,401.23%
[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="688321"]

Key Data [addtoany]

Current price $19.83
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Today's High/Low $20.79/$19.52
Volume 6,619,170.00
Previous Close $20.79
52 Week High/Low $31.49/$12.47
Market Cap 8,550,657,024.00
P/E Ratio 94.5
Forward P/E 1 Yr. $0.00
Earnings Per Share(EPS) $0.23
Annualized Dividend $0
$19.83
[addtoany]

Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research, development, and sale of original small molecule drugs. The company develops precursor compounds and original new drug product lines that are in various research phase of the specific global intellectual property protection in three areas, such as cancer, metabolic diseases, and autoimmune diseases. Shenzhen Chipscreen Biosciences Co., Ltd. was founded in 2001 and is based in Shenzhen, China.

Annual Data | Millions of US $ except per share data
Cash on hand
Receivables
Inventory
Pre-Paid Expenses
Other Current Assets
Total Current Assets
Property, Plant, And Equipment
Long-Term Investments
Goodwill And Intangible Assets
Other Long-Term Assets
Total Long-Term Assets
Total Assets
Total Current Liabilities
Long Term Debt
Other Non-Current Liabilities
Total Long Term Liabilities
Total Liabilities
Common Stock Net
Retained Earnings (Accumulated Deficit)
Comprehensive Income
Other Share Holders Equity
Share Holder Equity
Total Liabilities And Share Holders Equity